Key result
CMR-derived normalized pulmonary transit time accurately predicted diastolic dysfunction (AUC 0.81; 95% CI 0.71-0.89; p<0.001) and mitral valve regurgitation.
Why the study?
Pulmonary transit time is a potentially useful marker for heart failure, leading investigators to evaluate its association with diastolic dysfunction and mitral valve regurgitation.
Can CMR-derived pulmonary transit time accurately predict the presence of diastolic dysfunction and mitral valve regurgitation in patients undergoing routine stress perfusion CMR?
Observational (n=83)
Can CMR-derived pulmonary transit time accurately predict the presence of diastolic dysfunction and mitral valve regurgitation in patients undergoing routine stress perfusion CMR?
Effect estimate: AUC 0.81 (95% CI 0.71-0.89)
p-value: p=<0.001
CMR-derived pulmonary transit time is a readily obtainable parameter that shows good diagnostic accuracy for identifying relevant diastolic dysfunction and mitral valve regurgitation.
PTT in routine CMR may aid DD/MVR assessment; leaves open need for prospective validation before practice change.
Introduction: Pulmonary transit time (PTT) is the time it takes blood to pass from the right ventricle to the left ventricle via the pulmonary circulation, making it a potentially useful marker for heart failure. We assessed the association of PTT with diastolic dysfunction (DD) and mitral valve regurgitation (MVR). Methods: We evaluated routine stress perfusion cardiovascular magnetic resonance (CMR) scans in 83 patients including assessment of PTT with simultaneously available echocardiographic assessment. Relevant DD and MVR were defined as exceeding Grade I (impaired relaxation and mild regurgitation). PTT was determined from CMR rest perfusion scans. Normalized PTT (nPTT), adjusted for heart rate, was calculated using Bazett’s formula. Results: Higher PTT and nPTT values were associated with higher grade DD and MVR. The diagnostic accuracy for the prediction of DD as quantified by the area under the ROC curve (AUC) was 0.73 (CI 0.61–0.85; p = 0.001) for PTT and 0.81 (CI 0.71–0.89; p < 0.001) for nPTT. For MVR, the diagnostic performance amounted to an AUC of 0.80 (CI 0.68–0.92; p < 0.001) for PTT and 0.78 (CI 0.65–0.90; p < 0.001) for nPTT. PTT values < 8 s rule out the presence of DD and MVR with a probability of 70% (negative predictive value 78%). Conclusion: CMR‐derived PTT is a readily obtainable hemodynamic parameter. It is elevated in patients with DD and moderate to severe MVR. Low PTT values make the presence of DD and MVR—as assessed by echocardiography—unlikely.
No takes yet. Share an insight, caveat, or question.
Segeroth et al. (2024) conducted an observational in Diastolic dysfunction and mitral valve regurgitation (n=83). Pulmonary transit time (PTT) and normalized PTT (nPTT) was evaluated on Prediction of diastolic dysfunction (DD) exceeding Grade I (AUC 0.81, 95% CI 0.71-0.89, p=<0.001). CMR-derived normalized pulmonary transit time accurately predicted diastolic dysfunction (AUC 0.81; 95% CI 0.71-0.89; p<0.001) and mitral valve regurgitation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: